Sofosbuvir-based regimens for HCV in stage 4-stage 5 chronic kidney disease. A systematic review with meta-analysis

By sjmartinez • September 28, 2022

Fabrizi F, Cerutti R, Dixit V, Ridruejo E. Sofosbuvir-based regimens for HCV in stage 4-stage 5 chronic kidney disease. A systematic review with meta-analysis. Nefrologia (Engl Ed). 2021 Sep-Oct;41(5):578-589. doi: 10.1016/j.nefroe.2021.11.011. PMID: 36165141.

Tags: Acontecimientos adversos, Adverse events, Antivíricos de acción directa, Diálisis, dialysis, Digestive Diseases, Direct-acting antivirals, Hepatitis C, Publications, Respuesta virológica, Sofosbuvir

Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease

Mahurkar-Joshi S, Thompson M, Villarruel E, Lewis JD, Lin LD, Farid M, Nayeb-Hashemi H, Storage T, Weiss GA, Limketkai BN, Sauk JS, Mayer EA, Chang[...]

Unusual Cutaneous Metastasis in a Patient with Cholangiocarcinoma

Dong E, Yashar S, Mandelkern M, Kaunitz J. Unusual Cutaneous Metastasis in a Patient with Cholangiocarcinoma. Dig Dis Sci. 2024 Dec 11. doi: 10.1007/s10620-024-08775-1. Epub[...]

JPEN Journal Club 89. Signal-finding studies

Koretz RL. JPEN Journal Club 89. Signal-finding studies. JPEN J Parenter Enteral Nutr. 2024 Dec 10. doi: 10.1002/jpen.2709. Epub ahead of print. PMID: 39659167.